Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Scarfi MR et al. | 1997 | intact cell/cell culture, human lymphocytes | magnetic field, 50/60 Hz | 1 mT |
Loberg LI et al. | 2000 | intact cell/cell culture, <i>Ataxia telangiectasia</i> and normal human lymphoblastoid cell lines | magnetic field, 50/60 Hz, co-exposure | 1 mT |
Loberg LI et al. | 2000 | intact cell/cell culture, MCF-7, ZR-75-1, T-47D, and MDA-MB-231 (breast cancer cell line) and normal human breast epithalial cells | magnetic field, 50/60 Hz | 1 mT |
Bodega G et al. | 2005 | intact cell/cell culture, astroglial cells of P0-P1 Wistar rats | magnetic field, static magnetic field, 50/60 Hz | 1 mT |
Santini MT et al. | 2006 | small, proliferating MG-63 spheroids | magnetic field, 50/60 Hz | 1 mT |
Pica F et al. | 2006 | intact cell/cell culture, BCBL-1 (a latently infected primary effusion lymphoma-derived cell line) | magnetic field, 50/60 Hz | 1 mT |
Jacobi-Elizondo JS et al. | 2001 | intact cell/cell culture, L5178Y-R cells (mouse lymphoma cell line), animal, mouse/BALB/c, whole body | magnetic field, 50/60 Hz | 1 mT |
Vianale G et al. | 2008 | intact cell/cell culture, HaCaT cells (human keratinocytes) | magnetic field, 50/60 Hz | 1 mT |
Delle Monache S et al. | 2008 | intact cell/cell culture, human vein endothelial cells (HUVEC) | magnetic field, low frequency, 50/60 Hz | 1 mT |
Patruno A et al. | 2010 | intact cell/cell culture, HaCaT cells (human keratinocytes) | magnetic field, low frequency, 50/60 Hz, electrotherapy | 1 mT |
Marcantonio P et al. | 2010 | intact cell/cell culture, BE(2)C cells (human neuroblastoma cells) | magnetic field, low frequency, 50/60 Hz, co-exposure | 1 mT |
Sulpizio M et al. | 2011 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) | magnetic field, 50/60 Hz | 1 mT |
Liu C et al. | 2013 | intact cell/cell culture, rat bone marrow mesenchymal stromal cells | magnetic field, 50/60 Hz | 1 mT |
Bae JE et al. | 2013 | intact cell/cell culture, human prostate carcinoma cell lines (DU145) und Jurkat cells (human lymphoblastoid T cells) | magnetic field, 50/60 Hz | 1 mT |
Kim HJ et al. | 2013 | intact cell/cell culture, mesenchymal bone marrow stem cells | 50/60 Hz, magnetic field | 1 mT |
Leone L et al. | 2014 | intact cell/cell culture, neural stem cells from newborn mice, animal, mouse/C57bl/6, whole body | magnetic field, 50/60 Hz | 1 mT |
Yu JZ et al. | 2014 | intact cell/cell culture, mesenchymal bone marrow stem cells (rat) and osteoblasts (rat) | magnetic field, 50/60 Hz | 1 mT |
Jung IS et al. | 2014 | intact cell/cell culture, PC-12 cells (pheochromocytoma cell line from rat adrenal gland) | magnetic field, 50/60 Hz, co-exposure | 1 mT |
Hei WH et al. | 2016 | intact cell/cell culture, immortalized rat Schwann cells, animal, rat/Sprague-Dawley | low frequency, signals/pulses, 50/60 Hz, magnetic field | 1 mT |
Fan W et al. | 2015 | intact cell/cell culture, mesenchymal bone marrow stem cells (from SD rats) and mesenchymal stem cells (from mouse) | magnetic field, 50/60 Hz | 1 mT |
Patruno A et al. | 2015 | intact cell/cell culture, HaCaT cells (human keratinocytes) | magnetic field, 50/60 Hz, co-exposure | 1 mT |
Falone S et al. | 2016 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) | magnetic field, 50/60 Hz | 1 mT |
Ma Q et al. | 2016 | intact cell/cell culture, embryonic neural stem cells (mouse/BALB/c) | magnetic field, 50/60 Hz | 1 mT |
Bique AM et al. | 2016 | intact cell/cell culture, MC3T3-E1 cells (mouse osteoblast-like cell line) and SaOS-2 (cell line derived from human osteosarcoma) | magnetic field, 50/60 Hz | 1 mT |
Nasrabadi N et al. | 2018 | intact cell/cell culture, human retinal pigment epithelial cells | 50/60 Hz, signals/pulses, magnetic field | 1 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.